论文部分内容阅读
卓永清先生,在藤泽制药工作了26年,参与过研发、注册、生产、市场和销售等每个环节的工作,尤其对中国市场,更是倾注了许多心血。也正是凭着这种‘专业、专注、执着”的精神,藤泽制药在卓先生的带领下,积极地推动着中国器官移植事业的发展。 器官移植在中国 中国在器官移植领域进步很快。在中国,肝脏移植病例数1999年只有110例,2002年达到840例,今年预计
Mr. Zhuo Yongqing, who has worked in Fujisawa Pharmaceutical for 26 years, has participated in every aspect of R & D, registration, production, marketing and sales. In particular, he has devoted much effort to the Chinese market. It is also by virtue of this ’professional, dedicated and persistent’ spirit that Fujisawa Pharmaceutical Co., Ltd., under the leadership of Mr. Zhuo, has been actively promoting the development of organ transplant in China. Organ Transplantation in China China has made rapid progress in organ transplantation In China, the number of cases of liver transplants was 110 in 1999 and 840 in 2002. This year it is estimated